《大行報告》高盛下調萬科(02202.HK)目標價至18.7元 評級「買入」
高盛發表報告指,萬科(02202.HK)去年淨利潤按年持平為226億元人民幣,高於該行預期,主要是受到強勁收入和銷售、一般及行政開支(SG&A)較低所推動,並抵銷了合資企業收入較低,以及土地增值稅較高的影響。該行將公司在2023年至25年每股盈測調整為零、降4%及降4%,並將其目標價下調12%至18.7元。
該行仍然看好集團在以下方面的努力,包括持續關注現金流管理;重新集中總部層面開發業務的關鍵業務管理及決策;通過提升營運效率,爭取更多的發展機會和更好的回報,因此維持其評級為「買入」。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.